The four buyer archetypes in Indian M&A — and why each one prices you differently

Founders preparing for a sale process tend to ask one question first. What is the company worth. The honest answer is that the company is worth four different numbers, depending on who is in the room.

We have run enough processes across sectors — manufacturing, B2B SaaS, consumer brands, NBFC platforms — to see the pattern hold. The four buyer archetypes in Indian M&A each underwrite a different return, weight different diligence items, and structure their term sheets around different fears.

Worth knowing which archetype is sitting across the table before you negotiate.

The strategic acquirer

A strategic buyer is a corporate, usually operating in or adjacent to your sector, with a defined acquisition appetite supported by its own board. Think Tata Consumer buying a regional D2C brand, an Aditya Birla group company picking up a specialty chemicals platform, an HDFC entity absorbing an NBFC.

What the strategic wants: synergies. Revenue synergies if your customer base or geography complements theirs. Cost synergies if procurement, distribution or back-office can be folded in. Capability synergies if your IP, your team or your technology fills a gap they have been working around.

How they price. Strategics will overpay on EBITDA multiple if the synergy math justifies it. We have seen the same Indian B2B asset receive an 11x EBITDA bid from a PE buyer and a 16x bid from a strategic two months later. The strategic was paying for ₹40-50 crore of annual synergy capture over three years — the gap was the present value of those synergies, less an integration discount.

What they obsess over in diligence: customer overlap (will my customers walk if I lose this brand identity), regulatory consents (are key contracts assignable), management retention (will the senior team stay through integration), and cultural fit (this gets soft-pedalled in IMs but kills as many deals as price).

Term-sheet shape: cash-heavy, modest earn-out (12-24 months, usually revenue-based), longer non-compete (3-5 years), defined retention package for the top 10-15 leaders. Indemnity cushion of 10-20% in escrow for 18-24 months.

The financial sponsor — PE buyer

A private equity buyer is running fund-level IRR math. They have a target return — usually 20-25% IRR over a 5-year hold for mid-market funds — and every offer they make is back-solved from that.

What the PE buyer wants: a platform asset they can grow, optimise, and sell to a larger PE or strategic in five years at a higher multiple. Growth comes from bolt-on M&A, geographic expansion, operating leverage. Multiple expansion comes from professionalising the asset and selling to a more sophisticated buyer.

How they price. PE buyers pay on EBITDA multiples that, on the surface, look conservative relative to strategics. The reason is that 30-40% of their model is leverage. An 8x EBITDA purchase price funded with 4x EBITDA of debt only requires the sponsor to write a 4x equity cheque. The IRR math works at lower headline multiples because the equity base is smaller.

Indian PE buyers — ChrysCapital, Multiples, True North, Kedaara, the Indian arms of KKR, Carlyle, Bain — typically underwrite at 7-11x trailing EBITDA depending on growth profile and sector. They will stretch on growth assets but anchor hard on cash-flow predictability.

What they obsess over: management quality (can this team execute the value-creation plan without us), working capital normalisation (is the trailing EBITDA we are paying for actually sustainable), customer concentration (a top-3 customer at 40% of revenue is a 1-1.5x multiple haircut), and reps & warranties (institutional indemnity protection).

Term-sheet shape: cash and rollover equity. Founder is asked to roll 10-25% of proceeds into the PE-owned entity. Earn-outs are smaller (PE doesn't love contingent consideration as much as strategics) but management equity reserve of 5-10% is built into the post-close cap-table.

The roll-up consolidator

A roll-up is a sponsor-backed platform that has done one or two anchor acquisitions and is now buying tuck-ins to build scale. Think the wealth-management roll-ups, the healthcare diagnostic platforms, the regional cement consolidators, the B2B distribution platforms backed by a fund.

What the roll-up wants: revenue. Specifically, revenue with overlapping customer profile or geography that lets them claim integration without much disruption. Profitability matters less than revenue in the first wave because the thesis is multiple-arbitrage — buy ten companies at 5x EBITDA, integrate, sell the platform at 12x.

How they price. Roll-ups will pay on a revenue multiple if the platform exists and the integration playbook is proven. We have seen Indian B2B distribution roll-ups offer 1.0-1.5x revenue for tuck-ins that wouldn't fetch more than 6x EBITDA from a PE buyer. The revenue-multiple framing matters: if your EBITDA is 8% but revenue is ₹100 crore, a roll-up at 1.2x revenue pays you ₹120 crore — the same business at 8x EBITDA pays you ₹64 crore.

What they obsess over: customer transferability (can we keep the customer relationships through rebranding), supply chain or vendor consolidation potential, team cost rationalisation (where does the redundancy sit).

Term-sheet shape: cash, partial equity in the platform, aggressive earn-outs tied to retained-customer revenue at the 12- and 24-month marks. The earn-out is where the multiple-arbitrage thesis lives — the platform doesn't want to pay full value until customer retention is proven.

The distressed buyer

The fourth archetype shows up when the seller is under pressure — covenant breach, working capital stress, a CIRP filing under IBC, or a forced sale by a lender or regulator.

What the distressed buyer wants: assets at a discount to going-concern value. They are not paying for synergies, IRR, or revenue multiples. They are paying for the option value of buying a depressed asset and stabilising it.

How they price. Asset value (replacement cost, less depreciation, less liabilities assumed) or going-concern liquidation value (12-18 months of negative free cash flow underwritten until breakeven, subtracted from steady-state value). Either methodology produces offers that are typically 40-60% of what a healthy seller would receive in a normal process.

What they obsess over: hidden liabilities. The price is anchored to a liability schedule the seller has signed off on. Anything that surfaces post-close (undisclosed litigation, GST notices, employee dues, retro tax assessments) comes off the price or out of escrow. Distressed deals run at 15-25% of headline price held in escrow for 24-36 months.

Term-sheet shape: cash but with heavy escrow. Specific indemnities for identified risk areas. Conditions precedent that are essentially diligence outs in disguise. A distressed buyer can walk away cleanly until closing; a strategic or PE buyer usually cannot.

The same business gets four different prices not because the buyers are valuing it differently, but because they are buying different things from inside it. Strategics buy synergy. Sponsors buy IRR. Roll-ups buy revenue. Distressed buyers buy optionality.

Why this matters at the buyer-list stage

The buyer list at the start of a sell-side process is where this gets concrete. A list of fifteen names with five strategics, five PE buyers, three roll-ups and two distressed-aware funds will produce a wider price range than a list of fifteen names from a single archetype.

Wider price range is not a bad thing. It tells the founder where the value sits and lets the negotiation play archetypes off each other. A strategic bid at 14x EBITDA gives a PE buyer at 10x cover to stretch to 11.5x. A roll-up's revenue multiple gives the strategic a benchmark to defend its premium against.

What we tell founders at the buyer-list workshop: do not optimise for the highest bid from a single archetype. Optimise for the spread. The spread is what makes the negotiation real.

What the founder controls

Some things about which archetype shows up are exogenous. Sector consolidation, fund deployment cycles, public-market multiples — none of these are in the founder's control.

What is in the founder's control: the story told in the IM. The same business can be positioned as a synergy acquisition for a strategic (here's how our customer base fits yours), an IRR platform for a sponsor (here's the value-creation plan over five years), or a revenue acquisition for a roll-up (here's the customer overlap with the platform's existing footprint).

The story doesn't change the underlying business. It changes which archetype reads the IM and stays engaged through to a bid. Run the same business through three different IM angles and the buyer mix that responds will be different.

What we run at engagement

First working session: we lay out the four archetypes and ask the founder which they would accept as the buyer. Some founders rule out PE on day one (don't want a five-year hold with a sponsor on the board). Some rule out distressed (won't sell at a discount even under pressure). Some are open to all four.

Second working session: we map the buyer universe to archetypes and identify which IM angle pulls in which set. We then decide on a primary angle and a secondary angle the IM can flex into depending on early reads.

Third working session: pricing benchmarks by archetype. The founder walks away with four ranges, not one. The board sees the same. Nobody is surprised when the bids land in different shapes.

Most founders don't have the luxury of four archetypes responding to every process. The sector, size and timing matter. But running the sale with the four-archetype frame in mind is a meaningfully different exercise from running it with a single multiple in mind. The price range that results is wider, and the founder ends up with optionality that wouldn't have existed otherwise.